The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School: Pancreatic Neoplasms trials

The registry lists 12 Pancreatic Neoplasms studies with The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School as lead sponsor. 8 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 9No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic CancerRecruitingNCT07353645Phase 1/2
• CtDNA-guided Maintenance Therapy in Pancreatic CancerRecruitingNCT07054879
• NALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus NALIRIFOX as Conversion Therapy of Locally Advanced Pancreatic CancerNot yet recruitingNCT06669078Phase 2
• Nal-IRI/5-FU/LV Chemotherapy Combined With PD-L1 Inhibitor and Multi-target Anti-angiogenic Small Molecule±SBRT as Second-line Therapy in Metastatic Pancreatic Cancer PatientsRecruitingNCT06662006Phase 2
• Nimotuzumab Combined With mFOLFIRINOX/GX as Postoperative Adjuvant Therapy in Pancreatic CancerRecruitingNCT06389760Phase 2
• A Study of Trilaciclib Combined With mFOLFIRINOX in the Treatment of Patients With Advanced Pancreatic CancerRecruitingNCT06151262Phase 2
• AG Combined With Immunotherapy and SBRT in Patients With Potentially Resectable Pancreatic CancerNot yet recruitingNCT06080854Phase 2
• Penpulimab Combined With Anlotinib and Nab-paclitaxel Plus Gemcitabine as First-line Treatment for Advanced Metastatic Pancreatic CancerRecruitingNCT06051851Phase 2
• Concurrent Chemoradiotherapy Combined With Immunotherapy in Patients With Potentially Resectable Pancreatic CancerStatus unknownNCT05634564Phase 2
• A Study of Penpulimab and Anlotinib Plus Nab-paclitaxel and Gemcitabine for Metastatic Pancreatic Cancer.CompletedNCT05493995Phase 2
• A Real-world Study of Albumin-bound Paclitaxel in the Treatment of Pancreatic CancerStatus unknownNCT03768687
• Efficacy and Safety of Endoscopic Ultrasound Guided Fine-needle Injection of Dendritic Cells Vaccination Into Unresectable Pancreatic CancerStatus unknownNCT01897636Not applicable